Bioventus (BVS) EBITDA Margin (2020 - 2026)
Bioventus' EBITDA Margin was 14.05% in Q3 2026, down 2.29 percentage points from 16.34% a year earlier and down 5.58 percentage points from the prior quarter.
Powered by 
Analysis
Bioventus (BVS) EBITDA Margin (2020 - 2026) Analysis & Trends
On a trailing twelve-month basis, Bioventus' EBITDA Margin was 17.23% through Sep 26, 2026, up 1.28 percentage points year-over-year; for FY2025, it came in at 17.78%, up 11.78 percentage points from FY2024.
- EBITDA Margin has now increased for three consecutive years, with a five-year change of +2.25 percentage points (FY2020 to FY2025).
- In earlier years, EBITDA Margin was 5.99% in FY2024 (+10.75 pp), -4.75% in FY2023 (+17.08 pp), -21.84% in FY2022 (-32.73 pp) and 10.89% in FY2021 (-4.64 pp).
- The Q3 2026 figure marks the lowest quarterly EBITDA Margin since Q1 2025.
- Compared with a year earlier, EBITDA Margin was higher in six of the last eight quarters, with an average year-over-year change of +5.75 percentage points.
- The best year-over-year quarter for EBITDA Margin over five years was Q3 2023 (a gain of 101.47 percentage points); the worst was Q3 2022 (a drop of 94.88 percentage points).
- Per Business Quant data, BVS's EBITDA Margin in the three quarters before Q3 2026 was 19.63% (Q2 2026), 14.85% (Q1 2026) and 19.75% (Q4 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBITDA Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Thermo Fisher Scientific | 266.22 Bn | 242.86 Bn | 5.13 Bn | 25.44% |
| 2 | Abbott Laboratories | 191.31 Bn | 165.77 Bn | 7.39 Bn | 20.09% |
| 3 | Danaher | 166.16 Bn | 145.82 Bn | 3.84 Bn | 30.00% |
| 4 | Intuitive Surgical | 155.98 Bn | 136.40 Bn | 2.08 Bn | 25.90% |
| 5 | Medtronic | 130.05 Bn | 96.18 Bn | 6.34 Bn | 25.55% |
| 6 | Stryker | 123.40 Bn | 109.59 Bn | 4.25 Bn | - |
| 7 | Boston Scientific | 64.81 Bn | 60.48 Bn | 3.43 Bn | 23.14% |
| 8 | Edwards Lifesciences | 59.87 Bn | 43.18 Bn | 1.35 Bn | 20.05% |
| 9 | Medline | 53.84 Bn | 50.96 Bn | 1.93 Bn | 9.79% |
| 10 | Bioventus | 942.04 Mn | 846.16 Mn | 97.13 Mn | 14.05% |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Sep 26, 2026 | 14.05% |
| Jun 27, 2026 | 19.63% |
| Mar 28, 2026 | 14.85% |
| Dec 31, 2025 | 19.75% |
| Sep 27, 2025 | 16.34% |
| Jun 28, 2025 | 20.60% |
| Mar 29, 2025 | 13.51% |
| Dec 31, 2024 | 13.09% |
| Sep 28, 2024 | 11.46% |
| Jun 29, 2024 | -12.16% |
| Mar 30, 2024 | 12.91% |
| Dec 31, 2023 | 10.06% |
| Sep 30, 2023 | 13.45% |
| Jul 1, 2023 | 15.58% |
| Apr 1, 2023 | -63.49% |
| Dec 31, 2022 | 1.04% |
| Oct 1, 2022 | -88.02% |
| Jul 2, 2022 | 6.47% |
| Apr 2, 2022 | -7.65% |
| Dec 31, 2021 | 6.55% |
API Access
Bioventus EBITDA Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BVS&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "ebitda-margin", "ticker": "BVS", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=ebitda-margin&ticker=BVS&period=max&api_key=YOUR_API_KEY");
const data = await res.json();